Evidence map›Paper›PMID 41388103›Full record

ReviewSmall (Weinheim an der Bergstrasse, Germany)2026

Functionalizing Nucleic Acids: Synthesis and Purification Strategies for Bioconjugates as Biomaterials.

Nico Alleva, Jian Zhang, David Y W Ng, Tanja Weil, Torsten John

Abstract readReview
In one paragraph

Review in Small (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nico AllevaMax Planck Institute for Polymer Research, Ackermannweg 10, 55128, Mainz, Germany.ORCID https://orcid.org/0009-0003-4211-7944
Jian ZhangMax Planck Institute for Polymer Research, Ackermannweg 10, 55128, Mainz, Germany.ORCID https://orcid.org/0000-0002-7825-9034
David Y W NgMax Planck Institute for Polymer Research, Ackermannweg 10, 55128, Mainz, Germany.ORCID https://orcid.org/0000-0002-0302-0678
Tanja WeilMax Planck Institute for Polymer Research, Ackermannweg 10, 55128, Mainz, Germany.ORCID https://orcid.org/0000-0002-5906-7205
Torsten JohnMax Planck Institute for Polymer Research, Ackermannweg 10, 55128, Mainz, Germany.ORCID https://orcid.org/0000-0001-6059-5964

Funding

Alexander von Humboldt-StiftungDeutsche Forschungsgemeinschaft 364549901-TRR234-B08
6 · The paper itself

Abstract

Nucleic acids are fundamental to life, encoding and storing genetic information, catalyzing biological processes, and directing protein synthesis. The primary classes, DNA and RNA, have become increasingly significant in biomedical applications due to advances in stabilizing these structures against degradation and elucidating their molecular roles. Nucleic acids can be functionalized with polymers, peptides, proteins, lipids, saccharides and other functional units to yield hybrid biomaterials with tailored properties for nanomedicine and materials science. This review summarizes conjugation strategies and provides a critical overview of purification approaches, including chromatographic, membrane-based, and electrophoretic methods, highlighting their principles, advantages, and limitations. Emphasis is placed on the relationship between synthesis route and purification choice, as well as common challenges such as solubility, aggregation, and incomplete coupling. Broadly applicable strategies for the successful synthesis and purification of nucleic acid conjugates are discussed, along with an overview of recent approaches for conjugates with polymers, peptides, proteins, lipids and saccharides. Finally, strategies are summarized for obtaining high-purity conjugates suitable for biomedical and materials applications.

Indexed as

Biocompatible MaterialsNucleic AcidsBiocompatible MaterialsNucleic Acidsclick chemistryDNA nanotechnologyhybrid biomaterialsnucleic acid bioconjugatespurification techniquessolid‐phase synthesistherapeutic delivery

Identifiers

PMID41388103
PMCPMC12824566

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.